BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Lobbying for BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.
H.R. 10227, the INSULIN Act and Issues pertaining to FDA modernization; S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to grant funding for the Special Diabetes Program; Issues pertaining to pending legislation for reclassification of deceased donor islet cells.